A pharmacokinetic-pharmacodynamic model for neuromuscular blocking agents to predict train-of-four twitches

被引:2
|
作者
Eleveld, DJ [1 ]
De Haes, A [1 ]
Proost, JH [1 ]
Wierda, JMKH [1 ]
机构
[1] Res Grp Expt Anesthesiol & Clin Pharmacol, NL-9700 RB Groningen, Netherlands
关键词
neuromuscular relaxants; pharmacokinetics; models; computers; train-of-four stimulation;
D O I
10.1023/A:1024430413262
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The train-of-four (TOF) stimulation pattern consists of 4 stimuli (T1, T2, T3, and T4) at 2 Hz, and is used in daily anesthesiological practice to determine the degree of relaxation caused by muscle relaxants. At a surgical levels of relaxation the degree of relaxation can be estimated by counting the number of "measurable'' or "visible'' muscular reactions to the 4 stimuli in the TOF stimulation pattern (TOF count). During recovery relaxation can be estimated by calculating the TOF ratio (T4/T1). Bartkowski and Epstein described a pharmacokinetic-pharmacodynamic (PK-PD) model to predict TOF ratio by modifying and extending the PK-PD model as described by Sheiner to use a hypothetical distributed effect compartment described by a median equilibration rate constant and a dispersion parameter. We extended the Bartkowski and Epstein PK-PD model to simulate all four TOF twitches by including EC50 terms for T2 and T3. We fit this model to data from the pig and compared the results to fitted models using separate PD models for each TOF twitch ( extended Sheiner model). The extended Bartkowski and Epstein model fit the twitch height data from all four TOF twitches better than the extended Sheiner model and has fewer parameters.
引用
收藏
页码:105 / 118
页数:14
相关论文
共 50 条
  • [21] PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF ORAL HYPOGLYCEMIC AGENTS - AN UPDATE
    MARCHETTI, P
    NAVALESI, R
    CLINICAL PHARMACOKINETICS, 1989, 16 (02) : 100 - 128
  • [22] Comment regarding "A modified train-of-four ratio to assess rocuronium-induced neuromuscular block: A comparison with the usual train-of-four ratio"
    Haththotuwegama, Kishanee
    Bowdle, Andrew
    Jelacic, Srdjan
    Michaelsen, Kelly
    ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2023, 42 (05)
  • [23] Pharmacokinetic-pharmacodynamic model for spiramycin in staphylococcal mastitis
    Renard, L
    Sanders, P
    Laurentie, M
    Delmas, JM
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1996, 19 (02) : 95 - 103
  • [24] A PHARMACOKINETIC-PHARMACODYNAMIC MODEL FOR QUANTAL RESPONSES WITH THIOPENTAL
    SHANKS, CA
    AVRAM, MJ
    KREJCIE, TC
    HENTHORN, TK
    GENTRY, WB
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1993, 21 (03): : 309 - 321
  • [25] RECEPTOR BASED PHARMACOKINETIC-PHARMACODYNAMIC MODEL FOR CORTICOSTEROIDS
    DERENDORF, H
    HOCHHAUS, G
    MOLLMANN, H
    BARTH, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 159 - 159
  • [26] A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusion
    Westin, J.
    Willows, T.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S102 - S103
  • [27] A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusion
    Westin, J.
    Willows, T.
    Groth, T.
    Dougherty, M.
    Karlsson, M.
    Nyholm, D.
    Palhagen, S.
    MOVEMENT DISORDERS, 2008, 23 (01) : S84 - S85
  • [28] Pharmacokinetic-pharmacodynamic model for the anticholinergic effect of glycopyrrolate
    Penttilä, J
    Helminen, A
    Luomala, K
    Scheinin, H
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (02) : 153 - 158
  • [29] A pharmacokinetic-pharmacodynamic model for a muscle relaxant: Atracurium
    Nigrovic, V
    Gaspari, J
    Banoub, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 49 (04) : 325 - 332
  • [30] A Pharmacokinetic-Pharmacodynamic Model for Duodenal Levodopa Infusion
    Westin, Jerker
    Nyholm, Dag
    Palhagen, Sven
    Willows, Thomas
    Groth, Torgny
    Dougherty, Mark
    Karlsson, Mats O.
    CLINICAL NEUROPHARMACOLOGY, 2011, 34 (02) : 61 - 65